Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 28th – October 4th,... read more →
Canaccord Genuity Released a Comprehensive Research Report on MindMed Complete a with Bullish Buy Rating and Price Target The Leading Psychedelic Drug Development Company Also Submitted an Application to Uplist... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of August 31st - September 6th,... read more →
As the Psychedelics Industry Gains its Footing as a Better Way to Treat Mental Health, with More Companies Starting up and More Developments in Drug Therapies to Treat Certain Mental... read more →
While the Psychedelics Industry Continues Growing, Industry Insiders Are Looking to Broaden the Base of People and Enhance the Appeal of Psychedelic Drugs and Therapies What That Means for This... read more →
Psychedelics Gained Popularity as a Recreational Substance Once LSD Slipped Out of Labs in the Mid to Late 1960s Where Researchers Had Been Experimenting with it Since its Discovery by... read more →
MindMed Plans to Use the Phase 1 Study to Experiment with Dosing Methods to Better Understand How Humans React to Ayahuasca's Active Ingredient, DMT The Phase 1 Clinical Trials Will... read more →
After Getting Off to a Good Start as a Psychotherapeutic Tool By the Middle of the Last Century, It Looked Like Psychedelics Would Become Part of the Medical Mainstream Then... read more →
MindMed Has Developed New Technology That Could Help Shorten or Stop an Unwanted LSD Trip MindMed's 'LSD Neutralizer' Could Help the Industry Reduce the Stigma and Fear Associated with Psychedelics... read more →
Psychedelics Firm MindMed Raised $24 Million in Pre IPO Round Which Featured Kevin O'Leary and Bruce Linton Now Listed on the NEO, MMED Stock Was Very Active on its First... read more →
